Skip to main content
Fig. 9 | Cardiovascular Diabetology

Fig. 9

From: Countering adipose tissue dysfunction could underlie the superiority of telmisartan in the treatment of obesity-related hypertension

Fig. 9

Effect of telmisartan on visceral adipose tissue inducible nitric oxide synthase content in diet-induced obesity hypertension. a Section of the visceral adipose tissue in the control group showed mild diffuse cytoplasmic iNOS immunoreactivity. b Section of the visceral adipose tissue in the DIO group showed intense diffuse cytoplasmic iNOS immunoreactivity. c Section of the visceral adipose tissue in the DIO + Tel group showed moderate diffuse cytoplasmic iNOS immunoreactivity (iNOS IHC ×200 for a, b and c). d iNOS mRNA gene expression level in control, DIO and DIO + Tel groups (number of rats = 10/group. P < 0.05 considered significant, * significant when compared to the control group, • significant when compared to the DIO group)

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840